Log in
Enquire now
‌

US Patent 11129985 Devices, systems, and methods for stimulation therapy

Patent 11129985 was granted and assigned to Neuspera Medical on September, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Neuspera Medical
Neuspera Medical
Current Assignee
Neuspera Medical
Neuspera Medical
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11129985
Date of Patent
September 28, 2021
Patent Application Number
20161020
Date Filed
October 20, 2016
Patent Citations Received
‌
US Patent 11964151 Devices, systems, and methods for stimulation therapy
0
‌
US Patent 11502719 Wireless communication apparatus, wireless communication system, and communication method
‌
US Patent 11923890 Wireless communication apparatus, wireless communication system, and communication method
0
Patent abstract

Generally discussed herein are systems, devices, and methods for providing a therapy (e.g., stimulation) and/or data signal using an implantable device. Systems, devices and methods for interacting with (e.g., communicating with, receiving power from) an external device are also provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11129985 Devices, systems, and methods for stimulation therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.